AlphAIalphai — Financial news for AI agents
MarketBeatDEC 263 min read$MMSI

Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Consensus Recommendation of "Moderate Buy" by Analysts

Merit Medical Systems, Inc. (NASDAQ:MMSI) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $105.88. The company recently reported strong quarterly earnings and revenue, surpassing analyst estimates, and has set optimistic full-year 2025 guidance. Despite recent insider selling, institutional investors hold a significant portion of the stock.

Original reporting
MarketBeat · MarketBeat
Published Dec 26, 2025, 7:22 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Dec 26, 2025, 8:30 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Merit Medical Systems, Inc. (NASDAQ:MMSI) Given Consensus Recommendation of "Moderate Buy" by Analysts — source image
Source · MarketBeat
Decision brief

The 30-second read

$MMSIBullishMed
01

Why it matters

The positive earnings and analyst sentiment suggest a favorable short-term price movement, although insider selling warrants cautious monitoring.

02

Market read

The news is relevant primarily to investors and traders interested in the healthcare and medical device sectors, with limited broader market impact.

03

What to watch

Potential regulatory changes or macroeconomic factors could impact the sector and MMSI's performance, which are not reflected in current data.

Timing: short-term (1-3 months)

Background

Merit Medical Systems has recently reported strong quarterly earnings exceeding analyst expectations, coupled with optimistic full-year guidance, leading to a consensus 'Moderate Buy' rating.

Company-level read

Ticker impact

$MMSIBullishHigh confidence
Context

The news pertains directly to Merit Medical Systems, Inc. (NASDAQ:MMSI), providing relevant insights for trading decisions.

Expected impact

Potential short-term price appreciation of approximately 3-5% over the next 1-3 months.

Evidence & confidence

Strong earnings, positive analyst consensus, and favorable guidance underpin the bullish outlook. Insider selling is noted but does not outweigh institutional support.

Market effects

Sector

The medical devices sector may experience a slight positive bias due to MMSI's strong quarterly performance.

Regional

Limited regional impact; primarily relevant to US markets where MMSI is listed.

Global

Minimal global market impact given the company's size and sector.

Counterpoint

What could challenge this read

Some analysts may view insider selling as a sign of potential upcoming challenges, warranting caution.

Key entities

  • Company
    Merit Medical Systems, Inc.

    A medical device manufacturer specializing in interventional and diagnostic products.

Read at source← All news

Related articles

AUG 8
$MMSIMedAI 8/10

Merit Medical (MMSI) Q2 2026 Earnings Call Transcript

Merit Medical Systems (MMSI) reported Q2 2026 revenue of $418.8 million, up 10% GAAP, and non-GAAP EPS of $1.19. Non-GAAP operating margin was 22.6% and free cash flow $51.9 million. The company raised 2026 revenue guidance to $1.631B-$1.643B and non-GAAP EPS to $4.25-$4.35, and guided Q3 revenue to $408M-$413M.

fool.com6 min
JUL 31
$MMSIMedAI 8/10

These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 Results - Merit Medical

Merit Medical Systems Inc (NASDAQ:MMSI) posted better-than-expected earnings for the second quarter on Thursday. The company posted adjusted EPS of $1.19, beating market estimates of 96 cents per share. The company’s sales came in at $418.843 million versus expectations of $405.268 million. Merit Medical Systems raised its FY2026 adjusted EPS guidance from $4.01-$4.15 to $4.25-$4.35 and increased its sales forecast from $1.612 billion-$1.634 billion to $1.631 billion-$1.643 billion.

benzinga.com3 min
JUL 30
$MMSIMedAI 8/10

Merit Medical Systems (NASDAQ:MMSI) Reports Bullish Q2 CY2026, Stock Soars

Medical device company Merit Medical Systems (NASDAQ: MMSI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.5% year on year to $418.8 million. The company’s full-year revenue guidance of $1.64 billion at the midpoint came in 1.1% above analysts’ estimates. Its non-GAAP profit of $1.19 per share was 24% above analysts’ consensus estimates. Is now the time to buy Merit Medical Systems? Find out by accessing our full research report, it’s free.

financialcontent.com4 min
JUL 30
$MMSIHigh

MERIT MEDICAL SYSTEMS INC (MMSI): Results of Operations and Financial Condition

MERIT MEDICAL SYSTEMS INC (MMSI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 mmsi-20260730xex99d1.htm EX-99.1 Exhibit 99.1 ​ ​ ​ ​ ​ ​ ​ ​ Contacts: ​ ​ ​ ​ PR/Media Inquiries: Sarah Comstock Merit Medical Investor Inquiries: Mike Piccinino, CFA, IRC ICR Healthcare ​ ​ +1-801-432-2864 +1-443-213-0509 ​ ​ sarah.comstock@merit.com mike.piccinino@i

SEC EDGAR 8-K6 min
AUG 8
$SUNEMedAI 8/10

Pentagon to invest $400m in Australian rare earth mine

Sunrise Energy Metals said the US Pentagon will provide a conditional $400 million loan commitment to develop Syerston, a proposed scandium mine in Fifield, NSW. The project targets Western supply of scandium used in defence and other sectors amid China’s export restrictions. Sunrise also said it has a deal with Lockheed Martin for 25% of output for five years.

bssnews.net4 min